Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's total assets are โน2.203 Trillion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | โน2.211 T | -6.04% |
2023-12-31 | โน2.353 T | 0.56% |
2022-12-31 | โน2.340 T | -6.18% |
2021-12-31 | โน2.495 T | 70.42% |
2020-12-31 | โน1.464 T | 12.85% |
2019-12-31 | โน1.297 T | 18.03% |
2018-12-31 | โน1.099 T | 0.61% |
2017-12-31 | โน1.092 T | 3.42% |
2016-12-31 | โน1.056 T | -24.16% |
2015-12-31 | โน1.393 T | -15.91% |
2014-12-31 | โน1.656 T | 6.3% |
2013-12-31 | โน1.558 T | 39.58% |
2012-12-31 | โน1.116 T | 10.65% |
2011-12-31 | โน1.008 T | 28.75% |
2010-12-31 | โน783.68 B | -2.68% |
2009-12-31 | โน805.22 B | 8.75% |
2008-12-31 | โน740.44 B | 23.36% |
2007-12-31 | โน600.21 B | -7.72% |
2006-12-31 | โน650.44 B | 13.57% |
2005-12-31 | โน572.71 B | -6.52% |
2004-12-31 | โน612.67 B | -1.83% |
2003-12-31 | โน624.07 B | 4.3% |
2002-12-31 | โน598.37 B | 19.9% |
2001-12-31 | โน499.06 B |